# Cloverleaf Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cloverleaf-bio

- Industry: Biotechnology
- Headquarters: US
- Website: www.cloverleafbio.com/
- Total disclosed funding: $33M
- Latest round: Seed (Sep 8, 2026)
- Investors on record: 7

## About

Founded in 2023 and based in Connecticut, US, Cloverleaf Bio provides RNA and programmable tRNA therapeutics for cancer treatment.

## Funding rounds

- Seed, Sep 8, 2026, $33M — Boehringer Ingelheim Venture, Eli Lilly and Company, AbbVie Ventures, Draper, Mission Biocapital, 4BIO Capital Partners, BrightEdge Ventures

## Investors

- Boehringer Ingelheim Venture (https://capitalatlas.ai/funds/boehringer-ingelheim-venture) — Seed
- Eli Lilly and Company — Seed
- AbbVie Ventures (https://capitalatlas.ai/funds/abbvie-ventures) — Seed
- Draper (https://capitalatlas.ai/funds/draper) — Seed
- Mission Biocapital (https://capitalatlas.ai/funds/mission-biocapital) — Seed
- 4BIO Capital Partners (https://capitalatlas.ai/funds/4bio-capital-partners) — Seed
- BrightEdge Ventures (https://capitalatlas.ai/funds/brightedge-ventures) — Seed